Creating the world’s most diverse
Genomic Bio/Data Bank
Diversity advances genomics-led drug discovery.
Caucasians comprise 4 in 5 of available genomic sequences for analysis. This data is way too homogeneous. Know more about the problem arising out of this limited diversity and what Anuva is doing about it.
Genomic Bio/Data Bank is a paradigm shift in genomics.
Diversity is indispensable to unlock the potential of genomics. However, researchers need far more than just sequence data. Anuva’s Genomic Bio/Data Bank empowers them to create new knowledge not possible with DNA sequence data alone.
A translational research company that inspires trust.
Collecting genomic data from diverse populations as well as blending it with data on disease traits to create richer interpretation are both specializations in themselves. Rather than work on data, can drug discovery teams get a partner who can provide what they need?
As the science community embarks on a genomics-led revolution in drug discovery and development, it is helpful to take a bird’s-eye view of where we stand now.
Is genomics in drug discovery and development proven? Read about the impact of genomics on drug discovery and development.
Our co-founder Jonathan Picker shares thoughts on how he believes genomics will shape up in the this decade and beyond.